Literature DB >> 8662143

Difference between carcinoma of the lower esophagus and the cardia.

Y Tachimori1, H Kato, H Watanabe, M Sasako, T Kinoshita, K Maruyama.   

Abstract

We analyzed the records of patients with carcinoma of the lower esophagus and cardia. Mediastinal node involvement was found in 43% of the patients with squamous cell carcinoma of the lower esophagus, and the 5-year survival after mediastinal dissection for patients with mediastinal node involvement was 27%. Mediastinal node involvement was found in 19% of the patients with adenocarcinoma of the cardia involving the esophagus, and no patients with mediastinal node involvement survived more than 2 years. When the patients had mediastinal node involvement, survival curves were significantly different. There were large differences between these tumors in terms of the extent of lymph node involvement and the survival of patients with mediastinal lymph node involvement. It is incorrect to consider the behavior of these tumors identical and to treat the conditions similarly.

Entities:  

Mesh:

Year:  1996        PMID: 8662143     DOI: 10.1007/s002689900080

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

Review 1.  The role of radiation in the perioperative treatment of esophagogastric cancer.

Authors:  Kilian S May; Gary Y Yang; Nikhil I Khushalani
Journal:  Curr Treat Options Oncol       Date:  2011-03

2.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

3.  Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Authors:  Ines Gockel; Werner Kneist; Theodor Junginger
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

4.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

5.  Prognosis of upper-third gastric carcinoma patients with invasion of the lower esophagus.

Authors:  Seong Yeob Ryu; Jae Kyoon Joo; Jae Hyuk Lee; Dong Yi Kim
Journal:  Langenbecks Arch Surg       Date:  2008-05-16       Impact factor: 3.445

6.  Crossroads in the combined-modality management of gastroesophageal junction carcinomas.

Authors:  Smith Apisarnthanarax; Joel E Tepper
Journal:  Gastrointest Cancer Res       Date:  2008-09

7.  Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.

Authors:  Aaldert K Talsma; Chin-Ann J Ong; Xinxue Liu; Pieter van Hagen; Jan J B Van Lanschot; Huug W Tilanus; Richard H Hardwick; Nicholas R Carroll; Manon C W Spaander; Rebecca C Fitzgerald; Bas P L Wijnhoven
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

8.  Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis?

Authors:  Ines Gockel; Sina Heckhoff; Claudia M Messow; Werner Kneist; Theodor Junginger
Journal:  World J Surg Oncol       Date:  2005-06-24       Impact factor: 2.754

9.  New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology.

Authors:  K Dolan; R Sutton; S J Walker; A I Morris; F Campbell; E M Williams
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

10.  Developments in esophageal surgery for adenocarcinoma: a comparison of two decades.

Authors:  I Gockel; F S Sultanov; M Domeyer; U Goenner; Th Junginger
Journal:  BMC Cancer       Date:  2007-06-29       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.